UNSPSC 51181605: Methimazole

This classification denotes an antithyroid agent with the molecular formula C4H6N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 554Z48XN5E, chemically known as 1,3-dihydro-1-methyl-2h-imidazole-2-thione but generally known as methimazole, which bears US NIH Compound Identifier 1349907. European Medicines Agency schedules Thiamazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10967MIG.

UNSPSC 51181605 Methimazole is a Commodity code covering the procurement of this antithyroid pharmaceutical agent by state and local health systems, departments, and correctional facilities. State and local governments purchase methimazole primarily for inpatient and outpatient treatment of hyperthyroidism and thyroid storm in correctional healthcare settings, hospital pharmacies, and public health clinics. Issuing bodies under this code include state departments of corrections, county and municipal health departments, state hospital systems, and regional jail authorities. The pharmaceutical is typically procured through competitive sealed bidding (IFB) or reverse-auction cooperative purchasing vehicles, often as part of broader pharmacy formulary agreements or emergency stockpiling initiatives.

The source provided contains no recent state and local contract opportunities under this code, leaving the current geographic distribution and representative recent solicitations uncharacterized.